Does salmeterol increase mortality in patients with COPD?
Gerber
R B
RB
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA.
Kavuru
M
M
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D000420:Albuterol / Q000031:analogs & derivatives*; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000401:mortality*; D000068299:Salmeterol Xinafoate; D015996:Survival Rate
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D000068299:Salmeterol Xinafoate; D000420:Albuterol